Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
extension crawled date : 2021 - 11 - 10 save search
Eisai Presents Late-Breaker Updates On Lecanemab Clinical, Biomarker And Safety Data From Phase 2b Study Core And Open-Label Extension Across Five Years At Clinical Trials On Alzheimer's Disease (CTAD) Conference
Published: 2021-11-10 (Crawled : 21:00) - biospace.com/
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.0%
H: 1.44%
C: -1.15%
disease alzheimer ema phase 2 clinical trials trials phase 2b trial conference alzheimer’s alzheimer's disease alzheimer's biomarkers lecanemab
Exela Technologies, Inc. Announces Early Tender Results and Extension of Early Tender Time
Published: 2021-11-10 (Crawled : 14:00) - globenewswire.com
XELA | $1.95 -16.67% -20.0% 310K
|
Technology Services
|
| O: -3.03%
H: 1.25%
C: 0.0%
results
Pan American Silver drills new La Colorada Skarn extension with 77 metre interval containing 119 g/t Ag, 7.7% Pb and 13.62% Zn, and provides a project development update for the Skarn
Published: 2021-11-10 (Crawled : 10:00) - prnewswire.com
PAAS | $19.06 0.85% 0.0% 4.6M
|
Non-Energy Minerals
|
| O: 2.35%
H: 3.44%
C: -0.74%
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.